- Pharmaceutical companies
- Grifols
Grifols
Phone: +3434-93 571 00 00
Fax: 34-93 571 02 67
| Type | Sociedad Anónima |
|---|---|
| Traded as | |
| ISIN | ES0171996012 |
| Industry | Pharmaceuticals, chemicals |
| Founded | 1940 |
| Headquarters | Barcelona, Spain |
| Key people | Víctor Grífols Deu and Raimon Grifols Roura (Chairmen and CEOs) |
| Products | Plasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals |
| Revenue |
|
| Operating income |
|
| Net income |
|
| Total assets |
|
| Total equity |
|
| Number of employees |
|
| Website | www.grifols.com |
Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. We are an industry leader in producing plasma-derived medicines and transfusion medicine. Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies. We sell our products and services in more than 100 countries and regions and have subsidiaries in 30 of them. We aim to be a global leader in our markets and an industry reference for quality, safety and innovation.
For detailed contact information visit location pages below.
Grifols's locations around the world
Europe
Clinical Trials sponsored by Grifols
-
Grifols Therapeutics LLCInstituto Grifols, S.A.Retiré
-
Instituto Grifols, S.A.RésiliéSyndrome post-polioÉtats-Unis, Danemark, Espagne, Allemagne, Pologne, Canada, Tchéquie, Italie, Pays-Bas
-
Instituto Grifols, S.A.ComplétéLa sclérose latérale amyotrophiqueEspagne
-
Instituto Grifols, S.A.Complété
-
Instituto Grifols, S.A.Recrutement
-
Instituto Grifols, S.A.Instituto Grifols, S.A.RésiliéInsuffisance hépatique aiguë sur chroniqueÉtats-Unis, Espagne, France, Belgique, Italie, Allemagne, Royaume-Uni, L'Autriche, Le Portugal
-
Grifols Therapeutics LLCGrifols Japan K.K.Complété
-
Grifols Therapeutics LLCInstituto Grifols, S.A.ComplétéAfibrinogénémie congénitaleInde, États-Unis, Italie, Liban
-
Instituto Grifols, S.A.ComplétéSaignement chirurgical vasculaireÉtats-Unis, Hongrie, Fédération Russe, Serbie
-
Instituto Grifols, S.A.Grifols Biologicals, LLCComplétéLa maladie d'AlzheimerEspagne, États-Unis